NASDAQ: LNSRLensar Inc Stock
$3.14+0.08 (+2.61%)
Updated Apr 18, 2024
LNSR Price
$3.14
Fair Value Price
N/A
Market Cap
$35.78M
52 Week Low
$1.80
52 Week High
$5.30
P/E
-2.4x
P/B
1.07x
P/S
0.91x
PEG
N/A
Dividend Yield
N/A
Revenue
$42.16M
Earnings
-$14.38M
Gross Margin
50.1%
Operating Margin
-34.1%
Profit Margin
-34.1%
Debt to Equity
0.67
Operating Cash Flow
-$10M
Beta
0.37
Next Earnings
May 13, 2024
Ex-Dividend
N/A
Next Dividend
N/A
LNSR Overview
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how LNSR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
LNSR is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
LNSR is good value based on its book value relative to its share price (1.07x), compared to the US Medical Devices industry average (3.63x)
P/B vs Industry Valuation
LNSR is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more LNSR due diligence checks available for Premium users.
Be the first to know about important LNSR news, forecast changes, insider trades & much more!
LNSR News
Valuation
LNSR fair value
Fair Value of LNSR stock based on Discounted Cash Flow (DCF)
Price
$3.14
Fair Value
$4.14
Undervalued by
24.22%
LNSR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
LNSR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-2.4x
Industry
28.61x
Market
41.33x
LNSR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.07x
Industry
3.63x
LNSR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
LNSR's financial health
Profit margin
Revenue
$12.1M
Net Income
-$3.9M
Profit Margin
-32.4%
LNSR's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
LNSR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$69.6M
Liabilities
$22.4M
Debt to equity
0.67
LNSR's short-term assets ($46.44M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LNSR's short-term assets ($46.44M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LNSR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
LNSR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$480.0k
Investing
-$4.0M
Financing
$146.0k
LNSR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
LNSR vs Medical Device Stocks
Lensar Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.